Marvel Biosciences secures funding for autism drug trial from 5 Horizons
Go back to Marvel Biosciences secures funding for autism drug trial from 5 Horizons| (AMEX: MBCOF) | Delayed: 0.12 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.12 | 52 Week High | $ | |||
| Open | $0.12 | 52 Week Low | $ | |||
| Day High | $0.12 | P/E | N/A | |||
| Day Low | $0.12 | EPS | $ | |||
| Volume | 7,785 | |||||
| Marvell Technology Group Ltd (NASDAQ: MRVL) | Delayed: 307.86 -2.72 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $310.58 | 52 Week High | $13.61 | |||
| Open | $313.39 | 52 Week Low | $7.40 | |||
| Day High | $314.17 | P/E | 481.03 | |||
| Day Low | $298.18 | EPS | $0.64 | |||
| Volume | 49,193,154 | |||||
